medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2014, Number 3

<< Back Next >>

Arch Neurocien 2014; 19 (3)

Estimated time of crisis between home and surgical treatment in patients with refractory epilepsy

Guerrero-Pérez R, Aguado-Carrillo G, Vázquez-Barrón D, Velasco-Campos F, Velasco-Monroy AL

Language: Spanish
References: 23
Page: 153-156
PDF size: 107.65 Kb.


ABSTRACT

Epilepsy affects 2% of the world population. 30% of these patients are refractory to medical treatment; thus are candidates for surgery. Controlled epilepsy has serious physical, emotional, cognitive and social consequences. Hence the need for an early assessment to consider the benefits of surgery. Unfortunately, experience shows that in many centers surgery is delayed for several years. Objective: to evaluate the time it takes a patient is refractory to medical treatment from the onset of their seizures to surgery in epilepsy clinic of the General Hospital of Mexico. Material and methods: observational study, documentary retrospective of patients with refractory epilepsy who underwent surgery Epilepsy Clinic General Hospital of Mexico was conducted. Results: 272 patients undergoing various surgical procedures to control epilepsy January 1992 to June 2013 The age of onset of crisis was between 2 and 30 years old with a mean of 11 years were included. The time between onset of crisis and surgery was 2 years and a maximum of 32 years with a mean of 14.1 years. Conclusions: the delay in the evaluation for surgery is still very large. You need to do hard work at different levels of health care to ensure that patients are assessed earlier; therefore improve their quality expectations of life.


REFERENCES

  1. Mohanraj R, Brodie MJ. Diagnosing refractor y epilepsy: response to sequential treatment schedules. Eur J Neurol 2006; 13: 277-82.

  2. Wiebe S, Camfield P, Jetté N, Burneo JG. Epidemiology of epilepsy: prevalence, impact, comorbidity and disparities. Can J Neurol Sci 2009; 36(Suppl 2): S7-16.

  3. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen HW, MAthern G. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Satrategies. Epilepsia 2010; 51(6): 1069-77.

  4. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342:314-9.

  5. Wiebe S. Definition of drug –resistant epilepsy: is it evidence based?. Epilepsia 2013; 54(suppl 2): 9-12.

  6. Wiebe S, Blume WT, Gir vin JP, Eliasziw M: A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345(5): 311-8.

  7. Haneef Z, Stern J, Dewar S, Engel J. Referral pattern for epilepsy surgery after evidence-based recommendations. Neurol 2010; 75:699-704.

  8. Schachter SC. Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors. Expert Rev Neurother 2006;6(1):111-8.

  9. Shor von S, Luciano AL. Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects. Curr Opin Neurol 2007; 20: 208-12.

  10. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shor von SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000;48: 833-41.

  11. Kwuon CS, Liu M, Quan H, Wiebe S, McChesney, Wirrell E. The incidence of injuries in persons with and without epilepsya population-based study. Epilepsia 2010; 51(11): 2247-53.

  12. Sander JW. The natural history of epilepsy in the era of new antiepileptic drugs and surgical treatment. Epilepsia 2003; 44 (suppl 1): 17-20.

  13. Fiest KM, Dykeman J, Patten SB, Wiebe S, Kaplan GG, Maxwell CJ, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013; 80(6): 590-9.

  14. Chandra PS, Tripathi M. Epilepsy surgery: Recommendations for India. Ann Indian Acad Neurol 2010; 13(2): 87-93.

  15. Olivier A, Tanriverdi T. Surger y of temporal lobe epilepsy: modalities, advantages, disadvantages and outcomes. Future Neurol 2009; 4(3): 305-16.

  16. Rudzinski LA, Meador KJ. Epilepsy and neuropsychological comorbidities. Epilepsy 2013; 19(3): 682-96.

  17. Wiebe S. Effectiveness and safety of epilepsy surgery: what is the evidence?, CNS Spectr 2004; 9(2): 120-2.

  18. Cross JH, Jayakar P, Nordli D, Delalande O, Duchowny M, Wieser HG, Guerrini R, Mathern GW. Proposed criteria for referral and evaluation of children for epilepsy surger y: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006; 47 (6): 145-9.

  19. Blair R. Temporal lobe epilepsy semiology, Hindawi Publishing Corporation Epilepsy Research and Treatment Volume 2012.

  20. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46(4): 470-2.

  21. Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012; 307(9): 922-30.

  22. Wiebe S, Jette N. Pharmacoresistance and the role of surgery in difficult to treat epilepsy. Nat Rev Neurol 2012; 8(12): 669-77.

  23. Hrazdil C, Roberts JL, Wiebe S, Sauro K, Vautour M, Hanson A, et al. Patient perceptions and barriers to epilepsy surgery: evaluation in a large health region. Epilepsy Behav 2013; 28(1):52-65.




2020     |     www.medigraphic.com